Zhende Other Liab from 2010 to 2025
| 603301 Stock | 68.10 2.77 3.91% |
Other Liabilities | First Reported 2010-12-31 | Previous Quarter 231.8 M | Current Value 243.4 M | Quarterly Volatility 89 M |
Check Zhende Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zhende Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 249.2 M, Interest Expense of 24.5 M or Selling General Administrative of 305.6 M, as well as many indicators such as . Zhende financial statements analysis is a perfect complement when working with Zhende Medical Valuation or Volatility modules.
Zhende | Other Liab |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Zhende Stock
Zhende Medical financial ratios help investors to determine whether Zhende Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zhende with respect to the benefits of owning Zhende Medical security.